GlassScriptPhysician profile
Dwight L Fitch
NPI 1871540278
$3,894.53
in general payments reported to CMS, 2019-2025
16 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,698 · 2020: $15.64 · 2021: $146 · 2022: $120 · 2023: $340 · 2024: $202 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.40 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| West Therapeutics Development, LLC | $2,515.64 | 2019-2020 | |
| Novocure INC. | $316.68 | 2019-2025 | Optune, Optune Gio |
| Astrazeneca Pharmaceuticals LP | $149.23 | 2024-2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $141.93 | 2022-2023 | Myrisk |
| Sumitomo Pharma America, INC. | $116.98 | 2023-2025 | Orgovyx |
| Nalu Medical, INC. | $110.65 | 2021 | |
| Boston Scientific Corporation | $105.71 | 2022-2025 | Spaceoar Vue System - 10ml |
| Blue Earth Diagnostics | $105.39 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $98.93 | 2022-2025 | |
| Abiomed | $60.42 | 2023 | Impella |
| Bioprotect Medical, INC. | $36.17 | 2025 | Bioprotect Balloon Implant System |
| Myovant Sciences INC. | $35.24 | 2021 | |
| Teleflex LLC | $34.84 | 2025 | Barrigel |
| Gilead Sciences, INC. | $24.68 | 2025 | Trodelvy |
| Merck Sharp & Dohme LLC | $22.29 | 2024 | Keytruda |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $19.75 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Fitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.